Prabhudas Lilladher has issued an “Accumulate” rating on Cipla’s stock, suggesting a target price (TP) of Rs1,615 per share, with the current market price (CMP) standing at Rs1,478.

Prabhudas Lilladher reaffirms its "Buy" stance on Sun Pharmaceutical Industries Ltd. (SUNP), revising the target price to Rs.2,100 from Rs.1,885.

Prabhudas Lilladher has issued a BUY recommendation for Eris Lifesciences, setting a target price of Rs 1,420.

Morningstar has issued a HOLD recommendation on Merck & Co. Inc., maintaining a fair value estimate of $120, with the stock currently trading at $105.88.

KRChoksey has downgraded its stance on Laurus Labs to "ACCUMULATE" from "BUY," with a revised target price of Rs 489, implying a modest 5.4% upside from the current price of Rs 464.

Motilal Oswal has issued a BUY call on Piramal Pharma with a revised target price of Rs 310, indicating a 21% upside from its current market price of Rs 256.